Oxford Respiratory Trials Unit (ORTU)
 |
About ORTU
The Oxford Respiratory Trials Unit (ORTU) is a Clinical Trials Unit which specialises in the design, delivery, analysis and administration of trials across the broad scope of Respiratory Medicine and Respiratory Diseases.
We run national and international trials related to our academic areas of interest, as well as supporting trials led by other teams and industry. Our scope of work includes clinical trials at all phases, including translational studies, phase II discovery studies and multicentre definitive randomised trials.
We partner with a broad range of academic funders (National Institute of Health Research, Medical Research Council, British Lung Foundation, National Cancer Research Institute, CRUK) and partners in industry. Key funding for ORTU is derived from the NIHR Research Delivery Network (RDN) and the Oxford NIHR Biomedical Research Centre.
ORTU publications
-
Multidisciplinary management of adult patients with chylothorax: a consensus statement.
Journal article
Agrawal A. et al, (2024), The European respiratory journal, 64
-
Chest Tubes and Pleural Drainage: History and Current Status in Pleural Disease Management
Journal article
Sorino C. et al, (2024), Journal of Clinical Medicine, 13, 6331 - 6331
-
Complicated Pleural Infection is Associated With Prolonged Recovery and Reduced Functional Ability.
Journal article
Meggyesy AM. et al, (2024), Journal of bronchology & interventional pulmonology, 31
-
Reply to Ravaglia et al.: MIST-3 Is Well Worth an Echo!
Journal article
Bedawi EO. et al, (2024), American journal of respiratory and critical care medicine, 210, 695 - 696
-
Reply: Guideline recommendations don't exist in a vacuum.
Journal article
Walker S. et al, (2024), The European respiratory journal, 64
-
Navigational Bronchoscopy vs CT Scan-Guided Transthoracic Needle Biopsy for the Diagnosis of Indeterminate Lung Nodules: Protocol and Rationale for the Navigation Endoscopy to Reach Indeterminate Lung Nodules vs Transthoracic Needle Aspiration, a Randomized Controlled Study Multicenter Randomized Trial
Journal article
Lentz RJ. et al, (2024), CHEST Pulmonary, 2
-
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial
Journal article
Harris V. et al, (2024), The Lancet Infectious Diseases
-
Diagnostic utility of electrocardiogram for screening of cardiac injury on cardiac magnetic resonance in post-hospitalised COVID-19 patients: A prospective multicenter study.
Journal article
Samat AHA. et al, (2024), International journal of cardiology